Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) EBIT Margin (2024 - 2025)

Historic EBIT Margin for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to 62.54%.

  • Beta Bionics' EBIT Margin rose 31700.0% to 62.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 77.45%, marking a year-over-year change of. This contributed to the annual value of 69.48% for FY2024, which is 2293900.0% up from last year.
  • As of Q3 2025, Beta Bionics' EBIT Margin stood at 62.54%, which was up 31700.0% from 85.52% recorded in Q2 2025.
  • In the past 5 years, Beta Bionics' EBIT Margin registered a high of 62.54% during Q3 2025, and its lowest value of 105.69% during Q1 2025.